Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women

SUMMARY: Biosimilar teriparatide (INTG-8) was tested in a healthy population of males and postmenopausal females to assess pharmacokinetic bioequivalence to originator teriparatide comparator products. Primary pharmacokinetic comparison confirmed bioequivalence. Pharmacodynamics, safety, and tolerab...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenwick, Steven, Vekariya, Vishal, Patel, Ronak, Hajela, Pallavi, Modi, Ketul, Kale, Prashant, Nath, Akshaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813072/
https://www.ncbi.nlm.nih.gov/pubmed/36287230
http://dx.doi.org/10.1007/s00198-022-06573-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813072/
https://www.ncbi.nlm.nih.gov/pubmed/36287230
http://dx.doi.org/10.1007/s00198-022-06573-x

Ejemplares similares